Keros Therapeutics
KROS
#6211
Rank
โ‚น58.15 B
Marketcap
โ‚น1,436
Share price
-6.00%
Change (1 day)
-47.37%
Change (1 year)

Revenue for Keros Therapeutics (KROS)

Revenue in 2024 (TTM): โ‚น54.39 Million

According to Keros Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น55.23 Million. In 2023 the company made a revenue of โ‚น12.57 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Keros Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น54.39 M332.69%
2023 โ‚น12.57 M
2022 N/A-100%
2021 โ‚น1.49 B
2020 N/A-100%
2019 โ‚น0.71 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA